Investing.com - GlycoMimetics (NASDAQ:GLYC) reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that was in line with expectations.
GlycoMimetics announced earnings per share of $-0.160 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.250 on revenue of $0.
GlycoMimetics shares are down 0.45% from the beginning of the year, still down 67.26% from its 52 week high of $2.26 set on November 12, 2021.
GlycoMimetics shares gained 7.65% in intra-day trade following the report.
GlycoMimetics follows other major Healthcare sector earnings this month
GlycoMimetics's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar